Publications

Publications pour l'équipe Oncostat

Titre Publication Type Publication year Auteur
Factors which modulate the rates of skeletal muscle mass loss in non-small cell lung cancer patients: a pilot study journalArticle 2017 Atlan, P.; Bayar, M. A.; Lanoy, E.; Besse, B.; Planchard, D.; Ramon, J.; Raynard, B.; Antoun, S.
Feasibility of developing reliable gene expression modules from FFPE derived RNA profiled on Affymetrix arrays journalArticle 2018 Jose, V.; Fumagalli, D.; Rothé, F.; Majjaj, S.; Loi, S.; Michiels, S.; Sotiriou, C.
Feasibility Study of EndoTAG-1, a Tumor Endothelial Targeting Agent, in Combination with Paclitaxel followed by FEC as Induction Therapy in HER2-Negative Breast Cancer journalArticle 2016 Ignatiadis, M.; Zardavas, D.; Lemort, M.; Wilke, C.; Vanderbeeken, M. C.; D'Hondt, V.; De Azambuja, E.; Gombos, A.; Lebrun, F.; Dal Lago, L.; Bustin, F.; Maetens, M.; Ameye, L.; Veys, I.; Michiels, S.; Paesmans, M.; Larsimont, D.; Sotiriou, C.; Nogaret, J. M.; Piccart, M.; Awada, A.
Flexible modeling of disease activity measures improved prognosis of disability progression in relapsing-remitting multiple sclerosis journalArticle 2015 Le Teuff, G.; Abrahamowicz, M.; Wynant, W.; Binquet, C.; Moreau, T.; Quantin, C.
Follow-up of differentiated thyroid cancer - what should (and what should not) be done journalArticle 2018 Lamartina, L.; Grani, G.; Durante, C.; Borget, I.; Filetti, S.; Schlumberger, M.
French Health Technology Assessment Of Antineoplastic Drugs Indicated In The Treatment Of Solid Tumours: Perspective For Future Trends journalArticle 2015 Chouaid, C.; Borget, I.; Braun, E.; Bazil, M.; Schaetz, D.; Rémuzat, C.; Toumi, M.
French Intensive Care Society, International congress - Reanimation 2016 journalArticle 2016 Jaillette, E.; Girault, C.; Brunin, G.; Zerimech, F.; Chiche, A.; Broucqsault-Dedrie, C.; al
Genome-wide copy number analyses of samples from LACE-Bio project identify novel prognostic and predictive markers in early stage non-small cell lung cancer journalArticle 2018 Rotolo, F.; Zhu, C. Q.; Brambilla, E.; Graziano, S. L.; Olaussen, K.; Le-Chevalier, T.; Pignon, J. P.; Kratzke, R.; Soria, J. C.; Shepherd, F. A.; Seymour, L.; Michiels, S.; Tsao, M. S.
Germline SUFU mutation carriers and medulloblastoma: clinical characteristics, cancer risk, and prognosis journalArticle 2018 Guerrini-Rousseau, L.; Dufour, C.; Varlet, P.; Masliah-Planchon, J.; Bourdeaut, F.; Guillaud-Bataille, M.; Abbas, R.; Bertozzi, A. I.; Fouyssac, F.; Huybrechts, S.; Puget, S.; Bressac-De Paillerets, B.; Caron, O.; Sevenet, N.; Dimaria, M.; Villebasse, S.; Delattre, O.; Valteau-Couanet, D.; Grill, J.; Brugières, L.
GETUG-AFU 31: a phase I/II multicentre study evaluating the safety and efficacy of salvage stereotactic radiation in patients with intraprostatic tumour recurrence after external radiation therapy-study protocol journalArticle 2019 Pasquier, D.; Le Deley, M. C.; Tresch, E.; Cormier, L.; Duterque, M.; Nenan, S.; Lartigau, E.
Guidelines for time-to-event end point definitions in breast cancer trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials) journalArticle 2015 Gourgou-Bourgade, S.; Cameron, D.; Poortmans, P.; Asselain, B.; Azria, D.; Cardoso, F.; A'Hern, R.; Bliss, J.; Bogaerts, J.; Bonnefoi, H.; Brain, E.; Cardoso, M. J.; Chibaudel, B.; Coleman, R.; Cufer, T.; Dal Lago, L.; Dalenc, F.; De Azambuja, E.; Debled, M.; Delaloge, S.; Filleron, T.; Gligorov, J.; Gutowski, M.; Jacot, W.; Kirkove, C.; MacGrogan, G.; Michiels, S.; Negreiros, I.; Offersen, B. V.; Penault Llorca, F.; Pruneri, G.; Roche, H.; Russell, N. S.; Schmitt, F.; Servent, V.; Thürlimann, B.; Untch, M.; van der Hage, J. A.; van Tienhoven, G.; Wildiers, H.; Yarnold, J.; Bonnetain, F.; Mathoulin-Pélissier, S.; Bellera, C.; Dabakuyo-Yonli, T. S.
Health state utility and quality of life measures in patients with chronic myeloid leukemia in France journalArticle 2021 Foulon S, Cony-Makhoul P, Guerci-Bresler A, Daban M, Kapso R, Tubert-Bitter P, Bonastre J
Helping patients make informed decisions. Two-year evaluation of the Gustave Roussy prostate cancer multidisciplinary clinic journalArticle 2018 Patrikidou, A.; Maroun, P.; Patard, J. J.; Baumert, H.; Albiges, L.; Massard, C.; Loriot, Y.; Escudier, B.; Di Palma, M.; Arfi-Rouche, J.; Rocher, L.; Merabet, Z.; Bossi, A.; Fizazi, K.; Blanchard, P.
Hematopoietic stem cell transplantation in relapsed ALK+ anaplastic large cell lymphoma in children and adolescents: a study on behalf of the SFCE and SFGM-TC journalArticle 2015 Strullu, M.; Thomas, C.; Le Deley, M. C.; Chevance, A.; Kanold, J.; Bertrand, Y.; Jubert, C.; Dalle, J. H.; Paillard, C.; Baruchel, A.; Lamant, L.; Michel, G.; Brugieres, L.
High level of chromosomal instability in circulating tumor cells of ROS1-rearranged non-small-cell lung cancer journalArticle 2015 Pailler, E.; Auger, N.; Lindsay, C. R.; Vielh, P.; Islas-Morris-Hernandez, A.; Borget, I.; Ngo-Camus, M.; Planchard, D.; Soria, J. C.; Besse, B.; Farace, F.
High subcutaneous adipose tissue predicts the prognosis in metastatic castration-resistant prostate cancer patients in post chemotherapy setting journalArticle 2015 Antoun, S.; Bayar, A.; Ileana, E.; Laplanche, A.; Fizazi, K.; di Palma, M.; Escudier, B.; Albiges, L.; Massard, C.; Loriot, Y.
High-Dose Chemotherapy and Blood Autologous Stem-Cell Rescue Compared With Standard Chemotherapy in Localized High-Risk Ewing Sarcoma: Results of Euro-E.W.I.N.G.99 and Ewing-2008 journalArticle 2018 Whelan, J.; Le Deley, M. C.; Dirksen, U.; Le Teuff, G.; Brennan, B.; Gaspar, N.; Hawkins, D. S.; Amler, S.; Bauer, S.; Bielack, S.; Blay, J. Y.; Burdach, S.; Castex, M. P.; Dilloo, D.; Eggert, A.; Gelderblom, H.; Gentet, J. C.; Hartmann, W.; Hassenpflug, W. A.; Hjorth, L.; Jimenez, M.; Klingebiel, T.; Kontny, U.; Kruseova, J.; Ladenstein, R.; Laurence, V.; Lervat, C.; Marec-Berard, P.; Marreaud, S.; Michon, J.; Morland, B.; Paulussen, M.; Ranft, A.; Reichardt, P.; van den Berg, H.; Wheatley, K.; Judson, I.; Lewis, I.; Craft, A.; Juergens, H.; Oberlin, O.
How individual participant data meta-analyses have influenced trial design, conduct, and analysis journalArticle 2015 Tierney, J. F.; Pignon, J. P.; Gueffyier, F.; Clarke, M.; Askie, L.; Vale, C. L.; Burdett, S.; Cochrane, I. P. D. Meta-analysis Methods Group
How individual participant data meta-analyses have influenced trial design, conduct, and analysis journalArticle 2015 Tierney, J. F.; Pignon, J. P.; Gueffyier, F.; Clarke, M.; Askie, L.; Vale, C. L.; Burdett, S.; Cochrane, I. P. D. Meta-analysis Methods Group
How to Model Survival In Cost-Effectiveness Analysis? Differences Between Markov and Partitioned Survival Analysis Models journalArticle 2015 Minacori, R.; Bonastre, J.; Lueza, B.; Marguet, S.; Levy, P.
How to Model Survival In Cost-Effectiveness Analysis? Differences Between Markov and Partitioned Survival Analysis Models journalArticle 2015 Minacori, R.; Bonastre, J.; Lueza, B.; Marguet, S.; Levy, P.
How to Reliably Assess Nodal Status in Distal Pancreatectomy for Adenocarcinoma journalArticle 2018 Faron, M.; Vuarnesson, H.; Boher, J. M.; Bachellier, P.; Sauvanet, A.; Sa Cunha, A.; Le Treut, Y. P.; Mabrut, J. Y.; Delpero, J. R.; Paye, F.
Human epidermal receptor family inhibitors in patients with ERBB3 mutated cancers: Entering the back door journalArticle 2018 Verlingue, L.; Hollebecque, A.; Lacroix, L.; Postel-Vinay, S.; Varga, A.; El Dakdouki, Y.; Baldini, C.; Balheda, R.; Gazzah, A.; Michot, J. M.; Marabelle, A.; Mir, O.; Arnedos, M.; Rouleau, E.; Solary, E.; De Baere, T.; Angevin, E.; Armand, J. P.; Michiels, S.; André, F.; Deutsch, E.; Scoazec, J. Y.; Soria, J. C.; Massard, C.
Human metapneumovirus in patients hospitalized with acute respiratory infections: A meta-analysis journalArticle 2016 Lefebvre, A.; Manoha, C.; Bour, J. B.; Abbas, R.; Fournel, I.; Tiv, M.; Pothier, P.; Astruc, K.; Aho-Glele, L. S.
Human metapneumovirus in patients hospitalized with acute respiratory infections: A meta-analysis journalArticle 2016 Lefebvre, A.; Manoha, C.; Bour, J. B.; Abbas, R.; Fournel, I.; Tiv, M.; Pothier, P.; Astruc, K.; Aho-Glele, L. S.
Hyperprogressive Disease in Patients With Advanced Non-Small Cell Lung Cancer Treated With PD-1/PD-L1 Inhibitors or With Single-Agent Chemotherapy journalArticle 2018 Ferrara, R.; Mezquita, L.; Texier, M.; Lahmar, J.; Audigier-Valette, C.; Tessonnier, L.; Mazieres, J.; Zalcman, G.; Brosseau, S.; Le Moulec, S.; Leroy, L.; Duchemann, B.; Lefebvre, C.; Veillon, R.; Westeel, V.; Koscielny, S.; Champiat, S.; Ferte, C.; Planchard, D.; Remon, J.; Boucher, M. E.; Gazzah, A.; Adam, J.; Bria, E.; Tortora, G.; Soria, J. C.; Besse, B.; Caramella, C.
Hypertension and angiotensin system inhibitors: impact on outcome in sunitinib-treated patients for metastatic renal cell carcinoma journalArticle 2015 Izzedine, H.; Derosa, L.; Le Teuff, G.; Albiges, L.; Escudier, B.
Hypertension and angiotensin system inhibitors: impact on outcome in sunitinib-treated patients for metastatic renal cell carcinoma journalArticle 2015 Izzedine, H.; Derosa, L.; Le Teuff, G.; Albiges, L.; Escudier, B.
Hypofractionation for prostate cancer: a word of caution journalArticle 2016 Bossi, A.; Blanchard, P.
Hypofractionation for prostate cancer: a word of caution journalArticle 2016 Bossi, A.; Blanchard, P.
Identification de sous-groupes à l'aide de biomarqueurs de grande dimension dans les essais randomisés. Dirigée par Stefan Michiels & Federico Rotolo thesis Belhechmi Shaima
Image-guided tumour biopsies in a prospective molecular triage study (MOSCATO-01): What are the real risks? journalArticle 2018 Prud''''homme, C.; Deschamps, F.; Allorant, A.; Massard, C.; Hollebecque, A.; Yevich, S.; Ngo-Camus, M.; Gravel, G.; Nicotra, C.; Michiels, S.; Scoazec, J. Y.; Lacroix, L.; Solary, E.; Soria, J. C.; De Baere, T.; Tselikas, L.
Impact of dermatologic adverse events induced by targeted therapies on quality of life journalArticle 2016 Charles, C.; Bungener, C.; Razavi, D.; Mateus, C.; Routier, E.; Lanoy, E.; Verschoore, M.; Robert, C.; Dauchy, S.
Impact of dermatologic adverse events induced by targeted therapies on quality of life journalArticle 2016 Charles, C.; Bungener, C.; Razavi, D.; Mateus, C.; Routier, E.; Lanoy, E.; Verschoore, M.; Robert, C.; Dauchy, S.
Impact of early palliative care on overall survival of patients with metastatic upper gastrointestinal cancers treated with first-line chemotherapy: a randomised phase III trial journalArticle 2018 Hutt, E.; Da Silva, A.; Bogart, E.; Le Lay-Diomande, S.; Pannier, D.; Delaine-Clisant, S.; Le Deley, M. C.; Adenis, A.
Impact of experience in breast cancer surgery on survival: the role of quality of care in a registry-based cohort journalArticle 2019 Taban, F.; Elia, N.; Rapiti, E.; Rageth, C.; Fioretta, G.; Benhamou, S.; Than Lam, G.; David-Montefiore, E.; Bouchardy, C.
Impact of experience in breast cancer surgery on survival: the role of quality of care in a registry-based cohort. journalArticle 2018 Taban F, Elia N, Rapiti E, Rageth C, Fioretta G, Benhamou S, Than Lam G, David-Montefiore E, Bouchardy C
Impact of gender on efficacy and acute toxicity of alkylating agent -based chemotherapy in Ewing sarcoma: secondary analysis of the Euro-Ewing99-R1 trial journalArticle 2015 van den Berg, H.; Paulussen, M.; Le Teuff, G.; Judson, I.; Gelderblom, H.; Dirksen, U.; Brennan, B.; Whelan, J.; Ladenstein, R. L.; Marec-Berard, P.; Kruseova, J.; Hjorth, L.; Kuhne, T.; Brichard, B.; Wheatley, K.; Craft, A.; Juergens, H.; Gaspar, N.; Le Deley, M. C.; Euro, Ewing Group
Impact of gender on efficacy and acute toxicity of alkylating agent -based chemotherapy in Ewing sarcoma: secondary analysis of the Euro-Ewing99-R1 trial journalArticle 2015 van den Berg, H.; Paulussen, M.; Le Teuff, G.; Judson, I.; Gelderblom, H.; Dirksen, U.; Brennan, B.; Whelan, J.; Ladenstein, R. L.; Marec-Berard, P.; Kruseova, J.; Hjorth, L.; Kuhne, T.; Brichard, B.; Wheatley, K.; Craft, A.; Juergens, H.; Gaspar, N.; Le Deley, M. C.; Euro, Ewing Group
Impact of missing individual patient data on 18 meta-analyses of randomised trials in oncology: Gustave Roussy experience journalArticle 2018 Fayard, F.; Petit, C.; Lacas, B.; Pignon, J. P.